SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC ...
GENT, Belgium & AMSTERDAM--(BUSINESS WIRE)--Fujirebio Europe and Self-screen B.V. today announce a commercial collaboration around the distribution of the PreCursor-M+ methylation-specific molecular ...
YONGIN, South Korea, Sept. 1, 2022 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech startup, has obtained CE-IVD marks for two of its products. Based on this mark, Noul plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results